7Daoud J, Toumi N, Siala W, et al. Results of a prospective randomise trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma [J]. Radiother Oncol, 2007, 85 (1): 17-23.
8Jereczek-Fossa BA, Morra A, DeBraud F, et al. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer: An analysis of 43 consecutive patient [J]. Strahlenther Onkol, 2004, 180 (7) : 425-433.
10Lee N, Xia P. Three dinmensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinomaan update of experiences [J] . Int Radiat Oneol Biol Phys, 2002, 53: 12-22.
1AFQIR S,ISMAILI N,ERRIHANI H.Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma:current status[J].J Cancer Res Ther,2009,5:3-7.
2MA B B,KAM M K,LEUNG S F,et al.A phaseⅡstudy of concurrent cetuximab-cisplatin and intensitymodulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma[J].Ann Oncol,2012,23:1287-1292.
3YAN S,JIANG X,YANG J,et al.Radiotherapy for nasopharyngeal carcinoma and combined capecitabine and nimotuzumab treatment for lung metastases in a liver transplantation recipient:a case experience of sustained complete response[J].Cancer Biother Radiopharm,2012,27:519-523.
4CHUA D T,WEI W I,WONG M P,et al.PhaseⅡstudy of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma[J].Head Neck,2008,30:863-867.
5HE B F,SUN A M,HUANG B Y,et al.Gefitinib enhances the radiosensitivity of nasopharyngeal carcinoma cell line CNE2in vitro[J].Nan Fang Yi Ke Da Xue Xue Bao,2011,31:991-994.
6YOU B,LE TOURNEAU C,CHEN E X,et al.A PhaseⅡtrial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma[J].Am J Clin Oncol,2012,35:255-260.
7NIU X,HU C,KONG L.Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma[J].J Cancer Res Clin Oncol,2013,139:1063-1071.
